Efg Asset Management (North America) Corp. Catalent, Inc. Transaction History

Efg Asset Management (North America) Corp.

$585 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$45.44 - $74.26 $576,270 - $941,765	12,682 Added 24.43%	64,594 $4.24 Million
Q4 2022 Feb 03, 2023	BUY	$41.39 - $81.0 $482,690 - $944,622	11,662 Added 28.97%	51,912 $2.34 Million
Q3 2022 Oct 28, 2022	BUY	$72.36 - $113.1 $2.91 Million - $4.55 Million	40,250 New	40,250 $2.92 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

Vanguard Group Inc Valley Forge, PA

20.2M
Shares

$1.23 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

15.4M
Shares

$933 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$453 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$389 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$274 Million
0.14% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account